Results of a harmonized endotoxin recovery study protocol evaluation by 14 BioPhorum Operations Group (BPOG) member companies. (July 2017)
- Record Type:
- Journal Article
- Title:
- Results of a harmonized endotoxin recovery study protocol evaluation by 14 BioPhorum Operations Group (BPOG) member companies. (July 2017)
- Main Title:
- Results of a harmonized endotoxin recovery study protocol evaluation by 14 BioPhorum Operations Group (BPOG) member companies
- Authors:
- Bolden, Jay
Knight, Michael
Stockman, Shahrzad
Omokoko, Bastian - Abstract:
- Abstract: Significant regulatory and biopharmaceutical manufacturing attention has been recently generated regarding the inability to recover purified lipopolysaccharide in certain biopharmaceutical products, specifically those containing a chelator and surfactant. Disparate data has been generated and submitted during regulatory review. Study design is thought to significantly impact, and cause the confounding data. The BioPhorum Operations Group (BPOG) is an industry consortium of biopharmaceutical manufacturers. A BPOG team developed a collaborative experiment to determine if multiple laboratories could execute a harmonized protocol and reach equivalent conclusions. Twenty-one laboratories across fourteen different companies participated, yielding a robust study and large dataset. The experiment was successful as nearly all of the laboratories reached the same conclusions despite allowable variation in methods, suppliers, reagents, locations and analysts. The results of the study indicate a naturally occurring endotoxin analyte activity was recovered in a chelating buffer containing surfactant (citrate and polysorbate), and a buffer without surfactant (phosphate), while the purified lipopolysaccharide analyte activity was not recovered in the chelating buffer containing surfactant, but was recovered in the buffer without surfactant. Because the harmonized protocol yields consistent results across many different laboratories, the BPOG LER team recommends adoption of thisAbstract: Significant regulatory and biopharmaceutical manufacturing attention has been recently generated regarding the inability to recover purified lipopolysaccharide in certain biopharmaceutical products, specifically those containing a chelator and surfactant. Disparate data has been generated and submitted during regulatory review. Study design is thought to significantly impact, and cause the confounding data. The BioPhorum Operations Group (BPOG) is an industry consortium of biopharmaceutical manufacturers. A BPOG team developed a collaborative experiment to determine if multiple laboratories could execute a harmonized protocol and reach equivalent conclusions. Twenty-one laboratories across fourteen different companies participated, yielding a robust study and large dataset. The experiment was successful as nearly all of the laboratories reached the same conclusions despite allowable variation in methods, suppliers, reagents, locations and analysts. The results of the study indicate a naturally occurring endotoxin analyte activity was recovered in a chelating buffer containing surfactant (citrate and polysorbate), and a buffer without surfactant (phosphate), while the purified lipopolysaccharide analyte activity was not recovered in the chelating buffer containing surfactant, but was recovered in the buffer without surfactant. Because the harmonized protocol yields consistent results across many different laboratories, the BPOG LER team recommends adoption of this protocol for use in endotoxin recovery studies. … (more)
- Is Part Of:
- Biologicals. Volume 48(2017)
- Journal:
- Biologicals
- Issue:
- Volume 48(2017)
- Issue Display:
- Volume 48, Issue 2017 (2017)
- Year:
- 2017
- Volume:
- 48
- Issue:
- 2017
- Issue Sort Value:
- 2017-0048-2017-0000
- Page Start:
- 74
- Page End:
- 81
- Publication Date:
- 2017-07
- Subjects:
- Endotoxin -- Lipopolysaccharide -- Low endotoxin recovery (LER) -- Naturally occurring endotoxin (NOE) -- Biophorum Operations Group (BPOG)
Biological products -- Standards -- Periodicals
Biological Products -- Periodicals
Biological Products -- standards -- Periodicals
Produits biologiques -- Normes -- Périodiques
Biological products -- Standards
Periodicals
615.37 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10451056 ↗
http://www.elsevier.com/journals ↗
http://firstsearch.oclc.org/journal=1045-1056;screen=info;ECOIP ↗ - DOI:
- 10.1016/j.biologicals.2017.05.003 ↗
- Languages:
- English
- ISSNs:
- 1045-1056
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2081.670000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2826.xml